Why is this medication prescribed?

Risankizumab-rzaa is prescribed to treat moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. Plaque psoriasis is a chronic autoimmune skin condition characterized by raised, red, and scaly patches on the skin.

The medication works by targeting and inhibiting interleukin-23 (IL-23), a protein involved in the inflammatory process. By blocking IL-23, Risankizumab-rzaa helps to reduce the inflammation and symptoms associated with plaque psoriasis.

How should this medicine be used?

The specific dosage and administration of Risankizumab-rzaa can vary based on the prescribing physician’s recommendations and the individual patient’s condition. It is typically administered as an injection.

Common instructions for using Risankizumab-rzaa may include:

• Administration: The medication is usually administered as a subcutaneous injection, which means it is injected under the skin.
• Dosage: The dosage can vary. Your healthcare provider will determine the appropriate dose for your specific situation.
• Frequency: The injection schedule can vary, but it is often administered in the form of initial loading doses followed by maintenance doses at regular intervals.
• Administration Site: Healthcare providers will typically instruct patients on the proper technique for self-administration if the injections are to be given at home. The injection sites may rotate to minimize irritation.

It’s crucial for patients to follow their healthcare provider’s instructions carefully and attend regular follow-up appointments to monitor the medication’s effectiveness and address any potential side effects.

As medication information can change, it’s important to consult with a healthcare professional or refer to the most recent prescribing information and patient leaflet for Risankizumab-rzaa for the latest and most accurate guidance. Always consult your healthcare provider for personalized advice regarding your specific medical condition and treatment plan.

Other uses for this medicine

Risankizumab-rzaa is primarily approved for the treatment of moderate to severe plaque psoriasis. It specifically targets interleukin-23 (IL-23), which is involved in the inflammatory process associated with psoriasis. The approved uses for risankizumab-rzaa may have expanded since then, and it’s essential to consult with a healthcare professional or refer to the latest prescribing information for the most up-to-date details.

What special precautions should I follow?

Regarding special precautions, it’s crucial to consider the following general precautions. However, specific precautions can vary based on individual health conditions, and your healthcare provider will provide personalized guidance:

• Allergies: Inform your healthcare provider about any known allergies or reactions to medications, including biologic drugs or other components of risankizumab-rzaa.
• Infections: Risankizumab-rzaa may increase the risk of infections. Inform your healthcare provider if you have a history of chronic or recurrent infections, including tuberculosis. It’s important to be monitored for signs of infection during treatment.
• Vaccinations: Before starting risankizumab-rzaa, ensure that you are up-to-date on all recommended vaccinations. Avoid live vaccines during treatment.
• Pre-existing Conditions: Inform your healthcare provider about any pre-existing medical conditions, especially those related to the immune system, such as autoimmune diseases.
• Pregnancy and Breastfeeding: If you are pregnant, planning to become pregnant, or breastfeeding, discuss the risks and benefits of risankizumab-rzaa with your healthcare provider. The potential risks to the fetus or infant should be carefully considered.
• Monitoring: Regular monitoring, including blood tests and other assessments, may be necessary during treatment to evaluate the effectiveness of risankizumab-rzaa and detect any potential side effects.
• Adverse Reactions: Be aware of potential side effects or adverse reactions and promptly report any unusual symptoms or changes in your health to your healthcare provider.

It’s important to emphasize that the information provided here is general, and specific precautions can vary. Always follow the guidance of your healthcare provider and refer to the prescribing information for risankizumab-rzaa for the most accurate and current information. If you have any concerns or questions about your treatment, discuss them with your healthcare team.

What special dietary instructions should I follow?

As of last update, there were no specific dietary instructions associated with risankizumab-rzaa. However, it’s essential to maintain a healthy and balanced diet to support overall well-being. If you have specific dietary concerns or restrictions, discuss them with your healthcare provider or a registered dietitian.

What should I do if I forget a dose?

If you forget a dose of risankizumab-rzaa, contact your healthcare provider or follow their instructions. It’s essential not to self-adjust the dosage or attempt to make up for a missed dose without consulting your healthcare team. They can provide guidance on the best course of action based on your specific situation.

What side effects can this medication cause?

Risankizumab-rzaa, like any medication, may cause side effects. It’s important to note that individual responses to medications can vary, and not everyone will experience the same side effects. Additionally, the information provided here is based on last update and there may have been new developments or updates.

Common side effects associated with risankizumab-rzaa include:

• Upper Respiratory Tract Infections: This may include symptoms such as a cold or sinus infection.
• Headache: Some individuals may experience headaches during treatment.
• Fatigue: Feeling tired or having low energy levels.
• Injection Site Reactions: These can include redness, swelling, or pain at the injection site.

Serious side effects are less common but may include:

• Infections: Risankizumab-rzaa may increase the risk of infections, including serious bacterial, fungal, or viral infections. It’s important to contact your healthcare provider if you develop signs of infection, such as fever, cough, or persistent illness.
• Hypersensitivity Reactions: Some individuals may experience allergic reactions to the medication, and these can be serious. Seek immediate medical attention if you develop symptoms such as difficulty breathing, swelling of the face or throat, or severe rash.
• Inflammatory Bowel Disease: There have been reports of exacerbation of pre-existing inflammatory bowel disease.

It’s crucial to report any unusual or severe symptoms to your healthcare provider promptly. Additionally, discuss your medical history and any pre-existing conditions with your healthcare team before starting risankizumab-rzaa.

Since medication information can change, it’s essential to consult with your healthcare provider or refer to the most recent prescribing information for risankizumab-rzaa for the latest and most accurate details on potential side effects. Your healthcare provider can provide personalized information based on your health status and guide you on the management of side effects if they occur.

What should I know about storage and disposal of this medication?

Storage and Disposal of Risankizumab-rzaa:

Storage:

• Refrigeration: Risankizumab-rzaa may require refrigeration. Check the specific instructions provided with your medication. Follow the recommended temperature range and storage conditions.
• Protect from Light: Some medications are sensitive to light. If this applies to Risankizumab-rzaa, store it in its original packaging or container to protect it from light.
• Do Not Freeze: Do not freeze the medication unless directed otherwise.

Always follow the storage instructions provided with your specific medication. If you have any doubts about storage conditions, consult your healthcare provider or pharmacist.

Disposal:

• Dispose of Needles and Syringes Properly: If you are self-administering Risankizumab-rzaa with needles and syringes, dispose of them properly in a sharps disposal container. Do not throw them in the regular trash.
• Follow Local Regulations: Follow local regulations and guidelines for the disposal of unused or expired medications. Some communities have specific programs for medication disposal.
• Consult Your Pharmacist or Healthcare Provider: If you have questions about how to dispose of Risankizumab-rzaa or any other medication, consult your pharmacist or healthcare provider.

In case of emergency/overdose

In case of an emergency or suspected overdose, seek immediate medical attention. Contact your local poison control center or emergency room. Provide them with as much information as possible, including the name of the medication (Risankizumab-rzaa), the dose you took, and any symptoms you are experiencing.

What other information should I know?

• Follow Your Healthcare Provider’s Instructions: Always follow the dosing schedule and instructions provided by your healthcare provider. Do not adjust your dose without consulting them.
• Regular Monitoring: Your healthcare provider may conduct regular monitoring, including laboratory tests, to assess the effectiveness of the treatment and monitor for potential side effects.
• Communicate with Your Healthcare Provider: Report any new or worsening symptoms, side effects, or concerns to your healthcare provider promptly.
• Medical ID: In case of an emergency, it can be helpful to wear a medical identification bracelet or carry a card indicating that you are taking Risankizumab-rzaa. This provides important information to healthcare providers in case you are unable to communicate.

Always consult with your healthcare provider for personalized advice and guidance regarding Risankizumab-rzaa, including storage, disposal, and what to do in case of emergencies or overdose.